Tímea Pócza

1.2k total citations
15 papers, 126 citations indexed

About

Tímea Pócza is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Tímea Pócza has authored 15 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Tímea Pócza's work include BRCA gene mutations in cancer (6 papers), Genetic factors in colorectal cancer (6 papers) and Genomics and Rare Diseases (4 papers). Tímea Pócza is often cited by papers focused on BRCA gene mutations in cancer (6 papers), Genetic factors in colorectal cancer (6 papers) and Genomics and Rare Diseases (4 papers). Tímea Pócza collaborates with scholars based in Hungary, United States and Slovakia. Tímea Pócza's co-authors include E. Sylvester Vizi, Zsolt Selmeczy, Zoltán H. Németh, Anikó Bozsik, Henriett Butz, Attila Patócs, Balázs Koscsó, Pál Pacher, Bruce N. Cronstein and György Haskó and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Tímea Pócza

12 papers receiving 125 citations

Peers

Tímea Pócza
Derek Dang United States
Gozde Akgumus United States
Fabian Poetz Germany
Michaela Jackson United States
Malcolm F. Howard United Kingdom
Tímea Pócza
Citations per year, relative to Tímea Pócza Tímea Pócza (= 1×) peers Viorica Raluca Contu

Countries citing papers authored by Tímea Pócza

Since Specialization
Citations

This map shows the geographic impact of Tímea Pócza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tímea Pócza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tímea Pócza more than expected).

Fields of papers citing papers by Tímea Pócza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tímea Pócza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tímea Pócza. The network helps show where Tímea Pócza may publish in the future.

Co-authorship network of co-authors of Tímea Pócza

This figure shows the co-authorship network connecting the top 25 collaborators of Tímea Pócza. A scholar is included among the top collaborators of Tímea Pócza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tímea Pócza. Tímea Pócza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bozsik, Anikó, Tímea Pócza, Erika Tóth, et al.. (2025). Whole genome sequencing completes the molecular genetic testing workflow of patients with Lynch syndrome. npj Genomic Medicine. 10(1). 5–5. 1 indexed citations
2.
Pócza, Tímea, J. Papp, Anikó Bozsik, et al.. (2025). Double Pathogenic or Likely Pathogenic Variants in Cancer Predisposition Genes in Hungarian Cancer Patients. International Journal of Molecular Sciences. 26(17). 8390–8390.
3.
Patócs, Attila, J. Papp, Anikó Bozsik, et al.. (2024). Cost-effectiveness of Genetic Testing of Endocrine Tumor Patients Using a Comprehensive Hereditary Cancer Gene Panel. The Journal of Clinical Endocrinology & Metabolism. 109(12). 3220–3233. 5 indexed citations
4.
Papp, J., Vince Kornél Grolmusz, Anikó Bozsik, et al.. (2024). Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background. International Journal of Molecular Sciences. 25(23). 12546–12546. 3 indexed citations
5.
Bozsik, Anikó, Henriett Butz, Vince Kornél Grolmusz, et al.. (2024). Spectrum and genotyping strategies of “dark” genetic matter in germline susceptibility genes of tumor syndromes. Critical Reviews in Oncology/Hematology. 205. 104549–104549.
6.
Butz, Henriett, J. Papp, Anikó Bozsik, et al.. (2023). PALB2 Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer. Cancers. 15(17). 4350–4350. 3 indexed citations
7.
Grolmusz, Vince Kornél, István Likó, Henriett Butz, et al.. (2023). A common genetic variation in GZMB may associate with cancer risk in patients with Lynch syndrome. Frontiers in Oncology. 13. 1005066–1005066. 3 indexed citations
8.
Butz, Henriett, J. Papp, Anikó Bozsik, et al.. (2021). Application of Multilayer Evidence for Annotation of C-Terminal BRCA2 Variants. Cancers. 13(4). 881–881. 4 indexed citations
9.
Pócza, Tímea, Vince Kornél Grolmusz, J. Papp, et al.. (2021). Germline Structural Variations in Cancer Predisposition Genes. Frontiers in Genetics. 12. 634217–634217. 5 indexed citations
10.
Bozsik, Anikó, Tímea Pócza, J. Papp, et al.. (2020). Complex Characterization of Germline Large Genomic Rearrangements of the BRCA1 and BRCA2 Genes in High-Risk Breast Cancer Patients—Novel Variants from a Large National Center. International Journal of Molecular Sciences. 21(13). 4650–4650. 13 indexed citations
11.
Knoll, J., Kornélia Baghy, S. Eckhardt, et al.. (2017). A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain. Life Sciences. 182. 57–64. 7 indexed citations
12.
Pócza, Tímea, et al.. (2016). High expression of DNA methyltransferases in primary human medulloblastoma. Folia Neuropathologica. 2(2). 105–113. 9 indexed citations
13.
Pócza, Tímea, Anna Sebestyén, Eszter Turányi, et al.. (2014). mTOR Pathway As a Potential Target In a Subset of Human Medulloblastoma. Pathology & Oncology Research. 20(4). 893–900. 13 indexed citations
14.
Hauser, Péter, et al.. (2013). [Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].. PubMed. 57(4). 259–63.
15.
Himer, Leonóra, Balázs Csóka, Zsolt Selmeczy, et al.. (2010). Adenosine A 2A receptor activation protects CD4 + T lymphocytes against activation‐induced cell death. The FASEB Journal. 24(8). 2631–2640. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026